Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients (SAEI_IFN_1)

This study has been completed.
Sponsor:
Information provided by:
Sociedad Andaluza de Enfermedades Infecciosas
ClinicalTrials.gov Identifier:
NCT00553930
First received: November 3, 2007
Last updated: May 16, 2010
Last verified: May 2010